FDA advances peptide push to White House

FDA submits interim peptide access policy to White House for review

The Food and Drug Administration has submitted an interim access policy to the White House that would allow compounding pharmacies to temporarily produce and sell certain previously restricted peptides, a class of drugs favored by Health and Human Services Secretary Robert F. Kennedy Jr.